Drug Discovery World
MAY 16, 2023
Lentiviral vectors demand Naiara Tejados, Head of Marketing and Technology Development at VIVEbiotech & Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, anticipate that 2023 will be a very good year for VIVEbiotech, due to the increasing demand for lentiviral vectors.
Drug Discovery World
NOVEMBER 30, 2023
Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E. To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7
XTalks
OCTOBER 1, 2020
Dr. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. They felt there could be no one better than Dr. Lin to do business development and look for compounds that fit their drug delivery technology.
Expert insights. Personalized for you.
52 
Let's personalize your content